IB4SD-TRISTAN-1257964 Pre-clinical safety test for DIILD

Summary

For the most promising and or highest priority imaging biomarkers selected from those evaluated in deliverables D3.10 (3.03D1)- D3.16 (3.03D12) a commercial test is offered for preclinical safety evaluation.Responsible: TrulyVerification: Service offered on the companys website

More information & hyperlinks

Web resources:

https://ec.europa.eu/research/participants/documents/downloadPublic?documentIds=080166e5182523f9&appId=PPGMS

Associated projects

IB4SD-TRISTAN - Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106

Organisations

Not specified